When a bone is fractured, the body naturally generates a low-level electric field to stimulate healing. For some patients, however, the body’s natural healing processes are ineffective, and fractures experience delayed or non-union. Additionally, patients treated with spinal fusion procedures may have difficultly healing. A number of risk factors contribute to these outcomes, including osteoporosis, smoking, diabetes, obesity, and previously failed spinal fusion. Bone growth stimulators have been developed in order to promote healing in patients who are at risk for failed unions of long bone fractures or for spinal fusion.
Electrical stimulation using bone growth stimulators has long been considered a viable treatment option for fracture non-unions, failed unions, and failed spinal fusions. However, the efficacy of these devices is not well established, and potential patient benefit through their use on fresh fractures is currently under investigation. Continued research on these devices is necessary to grow the market, as positive data will precipitate a more favorable reimbursement scenario, thus increasing physician and patient adoption.
Key drivers of the bone growth stimulator market in the forecast period are:
- Growing elderly population and subsequent rise in fracture incidence, osteoporosis, and spinal disease
- Rising patient awareness of the availability and benefits of stimulation treatments
- Continued research into the efficacy of bone growth stimulators, resulting in improved reimbursement scenarios
Global bone growth stimulator market was estimated at $654.1M in 2016 across the 39 markets covered in this report. By the end of the forecast period in 2023, the author estimates the market will grow to approximately $801.4M at a Compound Annual Growth Rate (CAGR) of 2.9%.
The Middle East and Africa bone growth stimulators market is projected to grow fastest at a CAGR of 5.0% during the forecast period, followed by APAC market at 4.5%, North America, Europe and South America at 3.0%, 2.1% and 1.7% respectively. US represented the largest portion of the market in 2016, holding almost 98.0% of the regional revenue, and is expected to maintain this dominance through the forecast period. However, China is expected to be the fastest-growing market through 2023, at a CAGR of 6.0%, while the slowest growth will be observed in Japan at a CAGR of 1.0%.
Market for bone growth stimulators is fairly consolidated, with four multinationals dominating the global space. Bioventus, DJO Global, Orthofix, and Zimmer Biomet all enjoy high brand name recognition in this market, as well as established orthopedic portfolios and wide-ranging distribution networks. These bone growth stimulator manufacturers also play in complimentary markets, such as fixation devices or orthobiologics, in order to effectively cross-sell their products. The major players each focus on one type of stimulation method, with the exception of Zimmer Biomet, which has a portfolio that boasts two types of external stimulation as well as the only marketed implantable stimulators.
The report "MediPoint: Bone Growth Stimulators - Global Analysis and Market Forecasts" focuses on the market outlook for bone growth stimulator devices globally. This report analyzes and discusses the major drivers and barriers of bone growth stimulator adoption, and provides an in-depth understanding of the future outlook for this market by geography, with an overall emphasis on the current and future trends in the 39 key countries.
In particular, this report provides the following:
- Overview of recent key industry events and analysis of their market impact.
- Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.
- Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
- Analysis of the current and future market competition in the Global bone growth stimulator market. Insightful review of the key industry drivers, barriers, and challenges.
Companies mentioned in this report: Bioventus, DJO Global, IGEA, Orthofix, Zimmer Biomet.
*Note: This is an on-demand report and will be delivered within 3 working days (excluding weekends) of the purchase.
- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for bone growth stimulators.
- Company share analysis in 2016, for bone growth stimulators.
- Market insights and competitive assessment of the key players within bone growth stimulators market.
Reasons to buy
- Identify the unmet needs and understand physicians’ perceptions of the current bone growth stimulators
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global bone growth stimulators market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors
2 Executive Summary
2.1 Key Metrics
2.2 Market Dynamics
2.3 Key Players in the Bone Growth Stimulators Market
2.4 Bone Growth Stimulators Market Future Outlook
3.2 Related Reports
3.3 Upcoming Related Reports
4 Market Outlook
4.1 Procedure Trends
4.2 Pricing Trends
4.3 Revenue Trends
4.4 Company Share Analysis
5 Market Insights
5.1 North America
5.2.1 Denmark, Finland, Norway, and Sweden
5.2.2 Belgium, France, and Netherlands
5.2.3 Germany and Switzerland
5.2.4 UK and Ireland
5.2.5 Italy, Portugal, and Spain
5.2.6 Austria, Czech Republic, Hungary, and Poland
5.2.7 Greece, Russia, and Turkey
5.3.1 Australia and New Zealand
5.3.2 China and Taiwan
5.3.5 South Korea
5.4 South America
5.4.2 Argentina and Chile
5.5 Middle East and Africa
5.5.2 South Africa
5.5.3 Egypt, Saudi Arabia, and the United Arab Emirates
6 Competitive Assessment
6.1.2 Portfolio Assessment
6.1.3 Competitive Positioning
6.2 DJO Global
6.2.2 Portfolio Assessment
6.2.3 News and Deals Analysis
6.2.4 Competitive Positioning
6.3.2 Portfolio Assessment
6.3.3 Competitive Positioning
6.4.2 Portfolio Assessment
6.4.3 News and Deals Analysis
6.4.4 Competitive Positioning
6.5 Zimmer Biomet
6.5.2 Portfolio Assessment
6.5.3 News and Deals Analysis
6.5.4 Competitive Positioning
6.6 Other Players
7.3.3 Secondary Research
7.3.4 Forecasting Methodology
7.3.5 Primary Research Summary
7.4 About the Authors
7.4.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices
7.4.2 Linda Tian, Managing Analyst, Medical Devices
7.4.3 Tyler Fletcher, Global Head of Medical Devices
List of Tables
Table 1: Bone Growth Stimulators, Key Metrics, 2016 and 2023
Table 2: North America Procedure Volume Forecast for Bone Growth Stimulators, 2014-2023
Table 3: Europe Procedure Volume Forecast for Bone Growth Stimulators, 2014-2023
Table 4: APAC Procedure Volume Forecast for Bone Growth Stimulators, 2014-2023
Table 5: South America Procedure Volume Forecast for Bone Growth Stimulators, 2014-2023
Table 6: Middle East and Africa Procedure Volume Forecast for Bone Growth Stimulators, 2014-2023
Table 7: North America Bone Growth Stimulator Average Selling Price Forecast, 2014-2023
Table 8: Europe Bone Growth Stimulator Average Selling Price Forecast, 2014-2023
Table 9: APAC Bone Growth Stimulator Average Selling Price Forecast, 2014-2023
Table 10: South America Bone Growth Stimulator Average Selling Price Forecast, 2014-2023
Table 11: Middle East and Africa Bone Growth Stimulator Average Selling Price Forecast, 2014-2023
Table 12: North America Bone Growth Stimulator Market Revenue Forecast ($M), 2014-2023
Table 13: Europe Bone Growth Stimulator Market Revenue Forecast ($M), 2014-2023
Table 14: APAC Bone Growth Stimulator Market Revenue Forecast ($M), 2014-2023
Table 15: South America Bone Growth Stimulator Market Revenue Forecast ($M), 2014-2023
Table 16: Middle East and Africa Bone Growth Stimulator Market Revenue Forecast ($M), 2014-2023
Table 17: North America Bone Growth Stimulator Company Share Analysis, 2016
Table 18: Europe Bone Growth Stimulator Company Share Analysis, 2016
Table 19: APAC Bone Growth Stimulator Company Share Analysis, 2016
Table 20: South America Bone Growth Stimulator Company Share Analysis, 2016
Table 21: Middle East and Africa Bone Growth Stimulator Company Share Analysis, 2016
Table 22: Bioventus - Key Marketed Products Assessment
Table 23: Bioventus - Key Clinical Trials
Table 24: DJO - Key Marketed Products Assessment
Table 25: DJO - Key Clinical Trials
Table 26: IGEA - Key Marketed Products Assessment
Table 27: Orthofix - Key Marketed Products Assessment
Table 28: Orthofix - Key Clinical Trials
Table 29: Zimmer Biomet - Key Marketed Products Assessment
Table 30: Other Players Assessment
List of Figures
Figure 1: Global Bone Growth Stimulator Market Share Comparison, by Region, 2016 and